BC
AXSM icon

Brookfield Corp’s Axsome Therapeutics AXSM Stock Holding History

Brookfield Corp’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,526
Closed -$1.4M – 150
2023
Q2 		$1.4M Sell
19,526
-12,074
-38% -$891K 0.01% 442
2023
Q1 		$1.95M Buy
31,600
+20,822
+193% +$1.37M 0.01% 423
2022
Q4 		$831K Buy
+10,778
New +$644K ﹤0.01% 516
2022
Q3 		– Sell
-64,846
Closed -$2.48M – 634
2022
Q2 		$2.48M Buy
+64,846
New +$2.05M 0.01% 372

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return